Biostatistics is an essential component of all of the three major areas of cancer research - basic, clinical and population science. The Biostatistics Shared Resource (BSR) provides the necessary infrastructure to facilitate the collaboration between the investigator and a biostatistician from the planning stage of a project through its execution, analysis and interpretation and finally the dissemination stages. The objectives of this resource are: ? To collaborate with HICCC investigators in the design, conduct, analysis, interpretation and reporting of their clinical, laboratory and population science studies. ? To provide short-term statistical consulting to HICCC members. ? To collaborate with the HICCC investigators in their research initiatives and grant proposals. ? To advise the Protocol Review and Monitoring Committee by providing statistical review of the design of studies and their conduct. ? To interact with the Biomedical Informatics Shared Resource in the development and maintenance of the clinical research database. The Biostatistics Shared Resource has been part of the HICCC since its inception and it provides support for all of its members. This shared resource underwent significant personnel changes during the last grant period. The HICCC has appointed Dr. Venkatraman Seshan as the new Director of the BSR and has committed substantial institutional support to its growth in response to the demand for its services. Dr. Seshan joined Columbia University and HICCC in July 2007 and brings nearly 15 years of biostatistics experience specially focused on cancer research. Currently there are nine doctoral level biostatisticians with a wide range of methodological expertise and collaborative experience in the BSR representing an involvement of 3.5 FTEs in cancer research. In light of the plans for new recruitment and the institutional support for the growth, this resource is well positioned to cultivate and promote the collaborations between HICCC investigators and the biostatisticians that result in the highest quality cancer research. During the last period of the CCSG, the BSR has collaborated with 41 investigators, 56% of whom have been Cancer Center members with peer-reviewed funding. The total operating budget of the facility is $653,604 of which we are requesting $114,616 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013696-39
Application #
8375772
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
39
Fiscal Year
2012
Total Cost
$145,786
Indirect Cost
$55,267
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Villasante, A; Sakaguchi, K; Kim, J et al. (2017) Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma. Theranostics 7:4099-4117
Ma, Kevin K; Lin, James; Boudreault, Katherine et al. (2017) PHENOTYPING CHOROIDEREMIA AND ITS CARRIER STATE WITH MULTIMODAL IMAGING TECHNIQUES. Retin Cases Brief Rep 11 Suppl 1:S178-S181
Kampers, Johanna; Orjuela-Grimm, Manuela; Schober, Tilmann et al. (2017) Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leuk Lymphoma 58:633-638
Cabral, Thiago; DiCarlo, James E; Justus, Sally et al. (2017) CRISPR applications in ophthalmologic genome surgery. Curr Opin Ophthalmol 28:252-259
Velez, Gabriel; Bassuk, Alexander G; Colgan, Diana et al. (2017) Therapeutic drug repositioning using personalized proteomics of liquid biopsies. JCI Insight 2:
Dutta, Aditya; Panja, Sukanya; Virk, Renu K et al. (2017) Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5?-reductase Inhibition. Eur Urol 72:499-506
Chiang, Wei-Chieh; Chan, Priscilla; Wissinger, Bernd et al. (2017) Achromatopsia mutations target sequential steps of ATF6 activation. Proc Natl Acad Sci U S A 114:400-405
Marks, Lianna J; Oberg, Jennifer A; Pendrick, Danielle et al. (2017) Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience. Front Pediatr 5:265
Kanner, Scott A; Morgenstern, Travis; Colecraft, Henry M (2017) Sculpting ion channel functional expression with engineered ubiquitin ligases. Elife 6:
Wang, Tian; Tsang, Stephen H; Chen, Jeannie (2017) Two pathways of rod photoreceptor cell death induced by elevated cGMP. Hum Mol Genet 26:2299-2306

Showing the most recent 10 out of 263 publications